The Influence of Pharmaceutical Industry Advertising on Physician Prescribing

Abstract

Get full access to this article

View all access options for this article.

References

Association of the British Pharmaceutical Industry. Code of Practice Committee 1984 Pharmaceutical Journal 232:628–29.

Avorn

Chen

Hartley

1982 Scientific versus commercial sources of influence on the prescribing behavior of physicians. American Journal of Medicine 73:4–8.

Becker

Stolley

Lasagna

McEvilla

Sloane

1972 Correlates of physicians' prescribing behavior. Inquiry 9:30–42.

Branch

F.T.

1945 A comparison of direct mail and magazine cost in pharmaceutical advertising. Journal of Business 18:78–95.

Campbell

Stanley

1963 Experimental and Quasi-Experimental Designs for Research. Boston: Houghton Mifflin Company.

Caplow

1952 Market attitudes: A research report from the medical field. Harvard Business Review 30:105–112.

Caplow

Raymond

J.J.

1954 Factors influencing the selection of pharmaceutical products. Journal of Marketing 19(6):18–23.

Council on Ethical and Judicial Affairs of the American Medical Association 1991 Gifts to Physicians from Industry. JAMA 265:501.

Eaton

Parish

1976a General practitioners' views of information about drugs. Journal of the Royal College of General Practice 26:64–68.

10.

Eaton

Parish

1976b Sources of drug information used by general practitioners. Journal of the Royal College of General Practice 26:58–64.

11.

Editor 1983 Opren scandal. Lancet 1:219–220.

12.

Ethics Committee for the American College of Physicians 1990 Physicians and the pharmaceutical industry. Annals of Internal Medicine 112:624–626.

13.

Hemminki

1975 Review of literature on the factors affecting drug prescribing. Social Sciences and Medicine 9:111–116.

14.

Holland

A.E.

1977 Representatives and advertisements as sources of information. Postgraduate Medicine Journal 53:559–561.

15.

Jueck

J.E.

1940 Direct mail advertising to doctors. Journal of Business 13:17–38.

16.

Kass

1983 Seduction in a grand hotel. Reviews of Infectious Diseases 5:973–974.

17.

Linn

Davis

1972 Physicians' orientation toward the legitimacy of drug use and their preferred source of new drug information. Social Sciences and Medicine 6:199–203.

18.

Lurie

Rich

Simpson

Meyer

Schiedermayer

Goodman

McKinney

1990 Pharmaceutical representatives in academic medical centers. Journal of General Internal Medicine 5:240–243.

19.

McKinney

Schiedermayer

Lurie

Simpson

Goodman

Rich

1990 Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. Journal of the American Medical Association 264:1693–1697.

20.

Menzel

Katz

1955 Social relations and innovation in the medical profession: The epidemiology of a new drug. Public Opinion Quarterly 19:337–352.

21.

Miller

Gouveia

Barza

1985 Undesirable marketing practices in the pharmaceutical industry. New England Journal of Medicine 313:54.

22.

O'Malley

O'Hanrahan

1982 Drug promotion and the doctor. British Journal of Clinical Pharmacology 14:661–664.

23.

Rand

R.B.

1941 Pharmaceutical advertising to doctors. Journal of Business 14:150–168.

24.

Rawlins

1984 Doctors and the drug makers. Lancet 2:276–278.

25.

Smith

1977 Drug product advertising and prescribing: A review of the evidence. American Journal of Hospital Pharmacists 34:1208–1224.

26.

Stress

1987 Information sources and clinical decisions. Journal of General Internal Medicine 2:155–159.

27.

Winick

1961 The diffusion of an innovation among physicians in a large city. Sociometry 24:384–396.

28.

Working Party for the Royal College of Physicians 1986 The relationship between physicians and the pharmaceutical industry. Journal of the Royal College of Physicians of London 20:235–242.